Analyst consensus rating
LifeMD, Inc. Analyst Consensus Rating
LFMD analyst consensus rating, coverage count and price target evidence.
Direct answer
LifeMD, Inc.'s consensus rating is Strong Buy.
8 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $8.13.
Forecast evidence checked August 13, 2026.
Get free LifeMD, Inc. email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $3.46
- Average price target
- $8.13
- High price target
- $15.00
- Low price target
- $5.00
- Target upside
- +134.8%
- Consensus rating
- Strong Buy
- Analysts
- 8
- Evidence date
- August 13, 2026
- Valid through
- August 20, 2026